MedPath

Computerized Treatment for Social Anxiety

Not Applicable
Completed
Conditions
Social Anxiety Disorder
Interventions
Behavioral: Progressive Muscle Relaxation
Behavioral: Interpretation Bias Modification
Registration Number
NCT03101553
Lead Sponsor
Florida State University
Brief Summary

The present study aims to examine the feasibility of a computerized treatment for social anxiety disorder. To evaluate the efficacy of the IBM protocol the investigators have developed in reducing evaluation and social threat biases, they will conduct a two-arm randomized controlled trial. Individuals with a diagnosis of social anxiety disorder (N = 50) will be randomized to one of two conditions: 1) IBM or 2) progressive muscle relaxation. Each condition will consist of eight 25 minute treatment sessions. Participants will complete two sessions per week for four weeks and will be administered assessments at pre-treatment, one week post-treatment and at 3-month follow-up. It is hypothesized that: 1) IBM will lead to greater reductions in social anxiety symptoms than the PMR condition; 2) IBM will lead to greater reductions in depression and anxiety than the PMR condition; 3) IBM will lead to greater reductions in threat interpretations and greater increases in benign interpretations than the PMR condition; 4) The effects of condition on social anxiety symptoms will be mediated by changes in social anxiety-related interpretation bias; and 5) The effects of condition will be maintained at the 3-month follow-up assessment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Current diagnosis of Social Anxiety Disorder according to DSM-5 criteria
  • SPIN score greater than or equal to 30
  • Must report sufficient motivation to complete treatment (i.e., score of at least 5 on a 10 point scale (0 = no motivation and 10 = extreme motivation))
Exclusion Criteria
  • Concurrent psychotherapy or treatment for social anxiety disorder
  • Clinically significant suicidality
  • Current Alcohol Use Disorder of "Severe" severity or higher
  • Current Non-alcohol Substance Use Disorder of "Moderate" severity or higher
  • Recent changes (less than four weeks) in psychiatric medication
  • History of psychotic symptoms
  • May not have participated in a similar computerized treatment program

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Progressive Muscle RelaxationProgressive Muscle RelaxationParticipants will receive eight brief sessions of PMR. They will listen to a PMR script (Kassinove \& Tafrate, 2002). Participants will be asked to make sure they are sitting comfortably, close their eyes, and systematically tense and release different muscle groups.
Interpretation Bias ModificationInterpretation Bias ModificationTreatment consists of eight brief sessions consisting of two tasks. In Task 1, participants read unique scenarios ("You notice someone pointing in your direction"). A sentence meant to resolve the ambiguity will appear ("This person thinks they reco_nize you"). After filling in the missing letter, the interpretation is reinforced by requiring the participants to correctly answer "yes" or "no" to a comprehension question ("Is this person mocking you?"). In Task 2, participants are shown a word denoting a threatening ("mocking") or benign ("cheerful") interpretation. Participants are presented with an ambiguous scenario ("You hear people at a nearby table laughing") and asked to denote whether the word and the sentence are related. Participants will receive feedback based on their response.
Primary Outcome Measures
NameTimeMethod
Social Phobia Inventory (SPIN; Davidson, 1995)change from baseline at one-week post treatment and 3-months post-treatment

Measures past-week social anxiety symptom severity

Secondary Outcome Measures
NameTimeMethod
Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996)change from baseline at one-week post treatment and 3-months post-treatment

Measures depressive symptom severity

Beck Anxiety Inventory (BAI; Steer & Beck, 1997)change from baseline at one-week post treatment and 3-months post-treatment

Measure anxious symptom severity

Interpretations Questionnaire-modified (IQ-modified; Buhlmann et al., 2002)change from baseline at one-week post treatment and 3-months post-treatment

Measure of strength of evaluation related threat interpretation bias

Trial Locations

Locations (1)

Florida State University, Department of Psychology

🇺🇸

Tallahassee, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath